Oramed Pharmaceuticals (ORMP) Interest Coverage Ratio (2011 - 2024)

Oramed Pharmaceuticals (ORMP) reported Interest Coverage Ratio of 12.01 for Q2 2024, down 140.07% quarter-over-quarter from 5.0 in Q1 2024.

Oramed Pharmaceuticals (ORMP) Interest Coverage Ratio (2011 - 2024) Analysis & Trends

Oramed Pharmaceuticals has reported Interest Coverage Ratio for 11 years, with the latest figure at 12.01 in Q2 2024.

For the quarter ending Q2 2024, Interest Coverage Ratio changed N/A year-over-year to 12.01; the trailing twelve-month figure through Mar 2025 stood at 18.7 (down 1583.56% YoY), and the FY2024 full-year result was 3.92, down 847.49% from the prior year.
Interest Coverage Ratio for Q2 2024 stood at 12.01, down from 5.0 in the prior quarter.
The five-year high for Interest Coverage Ratio was 10.7 in Q4 2023, with the low at 12.01 in Q2 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Interest Cover (Qtr)
1	Alterity Therapeutics	762,369.55 Bn	762,369.51 Bn	-	-
2	Belite Bio	55,096.00 Bn	55,096.00 Bn	-	-
3	Quantum Biopharma	17,755.80 Bn	17,755.79 Bn	-	-
4	Legend Biotech	3,486.00 Bn	3,485.71 Bn	242.10 Mn	3.58
5	Akari Therapeutics	1,737.42 Bn	1,737.41 Bn	-	-258.33
6	Evaxion A	1,551.28 Bn	1,551.26 Bn	-	11.50
7	Psyence Biomedical	227.32 Bn	227.31 Bn	-	547.67
8	Vertex Pharmaceuticals	110.84 Bn	103.59 Bn	2.59 Bn	-
9	Abivax	91.71 Bn	91.71 Bn	-	11.79
10	Oramed Pharmaceuticals	151.47 Mn	133.31 Mn	-	-

Download Data